Assesment of thawed CD34+viability predicts engraftment kynetics in Autologous Peripheral Blood Stem Cells (PBSC) transplantation

被引:0
|
作者
Urbani, S. [1 ]
Anedotti, P. [1 ]
Bosi, A. [1 ]
Bufano, P. [1 ]
Carnarlinghi, C. [1 ]
Di Gioia, M. [1 ]
Dal Pozzo, S. [1 ]
Donnini, I. [1 ]
Gelli, A. [1 ]
Gozzini, A. [1 ]
Guidi, S. [1 ]
Materozzi, F. [1 ]
Nozzoli, C. [1 ]
Santosuosso, M. [1 ]
Sodi, I. [1 ]
Saccardi, R. [1 ]
机构
[1] AOU Careggi, Florence, Italy
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
P455
引用
收藏
页码:S349 / S350
页数:2
相关论文
共 50 条
  • [31] ADEQUATE ENGRAFTMENT AND COST REDUCTION WITH NON-CRYOPRESERVED (NC) PERIPHERAL BLOOD STEM CELLS (PBSC) IN MULTIPLE MYELOMA PATIENTS UNDERGOING AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION (APBSCT)
    Ibrahim, Ahmad
    Khalil, Ahmad
    Harmouch, Abir
    Noun, Peter
    Zahran, Kamal
    Khodr, Hawa
    Khalil, Charbel
    Moghnieh, Rima
    Youssef, Ali
    Hamandi, Ahmad
    Jisr, Tamima
    [J]. BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 487 - 488
  • [32] AUTOLOGOUS BONE-MARROW TRANSPLANTATION USING PERIPHERAL-BLOOD HEMATOPOIETIC PROGENITOR CELLS - THE TOTAL NUMBER OF CD34+ CELLS/KG PREDICTS FOR HEMATOLOGIC ENGRAFTMENT
    BITRAN, JD
    MARTINEC, J
    OKUNO, T
    WHITE, L
    HANAUER, S
    KLEIN, L
    SAMUELS, B
    [J]. BLOOD, 1993, 82 (10) : A288 - A288
  • [33] Autologous CD34 positive peripheral blood stem cell (PBSC) transplantation for acute promyelocytic leukemia (APL): Report of a case.
    Veinstein, A
    Sadoun, A
    Brizard, A
    Chomienne, C
    Guilhot, F
    [J]. EXPERIMENTAL HEMATOLOGY, 1997, 25 (08) : 485 - 485
  • [34] Selection and expansion of peripheral blood CD34(+) cells in autologous stem cell transplantation for breast cancer
    Williams, SF
    Lee, WJ
    Bender, JG
    Zimmerman, T
    Swinney, P
    Blake, M
    Carreon, J
    Schilling, M
    Smith, S
    Williams, DE
    Oldham, F
    VanEpps, D
    [J]. BLOOD, 1996, 87 (05) : 1687 - 1691
  • [35] Costs of autologous peripheral blood stem cell (PBSC) transplantation can be reduced by PB CD34 screening before apheresis.
    Areman, EM
    Rhodes, PL
    Meehan, KR
    Sacher, RA
    [J]. BLOOD, 1997, 90 (10) : 4198 - 4198
  • [36] PERIPHERAL-BLOOD STEM-CELLS (PBSC) FOR TRANSPLANTATION
    REIFFERS, J
    [J]. EXPERIMENTAL HEMATOLOGY, 1991, 19 (06) : 464 - 464
  • [37] Sequential mobilization and transplantation of peripheral blood stem cells (PBSC).
    JanowskaWieczorek, A
    Matsuzaki, A
    Sumoski, W
    Montano, J
    Lee, SF
    Turner, AR
    Sansregret, E
    Nabholtz, JM
    [J]. BLOOD, 1996, 88 (10) : 1604 - 1604
  • [38] The number of CD34+cells in peripheral blood as a predictor of the CD34+yield in patients going to autologous stem cell transplantation
    Basquiera, A. L.
    Abichain, P.
    Damonte, J. C.
    Ricchi, B.
    Sturich, A. G.
    Palazzo, E. D.
    Garcia, J. J.
    [J]. JOURNAL OF CLINICAL APHERESIS, 2006, 21 (02) : 92 - 95
  • [39] CD34+ cell dose predicts costs after autologous peripheral blood stem cell transplantation for breast cancer
    Baron, F
    Copizza, S
    Baudoux, E
    Jerusalem, G
    Fillet, G
    Beguin, Y
    [J]. HAEMATOLOGICA, 2004, 89 (09) : 1146 - 1148
  • [40] Hematopoietic recovery in cancer patients after transplantation of autologous peripheral blood CD34+ cells or unmanipulated peripheral blood stem and progenitor cells
    Beguin, Y
    Baudoux, E
    Sautois, B
    Fraipont, V
    Schaaf-Lafontaine, N
    Pereira, M
    Paulus, JM
    Sondag, D
    Fillet, G
    [J]. TRANSFUSION, 1998, 38 (02) : 199 - 208